Abstracts - faqs.org

Abstracts

Zoology and wildlife conservation

Search abstracts:
Abstracts » Zoology and wildlife conservation

NIH defends gene patents as filing deadline approaches

Article Abstract:

The National Institutes of Health (NIH) will extend its complementary DNA patents internationally before the Jun 20, 1992 deadline set by European and Japanese patent law despite domestic and foreign objections. Critics, including officials at the Department of Energy which is NIH's partner in the US genome project, fear that NIH's handling of the patents will hinder cooperation in genetic research. However, NIH director Bernadine Healy insists that the patents fall within legal precedent and Congressional mandate.

Author: Anderson, Christopher
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1992
International aspects, Patent extensions

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Gene wars escalate as US official battles NIH over pursuit of patent

Article Abstract:

Michael Astrue, general counsel for the Health and Human Services Department (HHS), has temporarily stopped the National Institutes of Health (NIH) from pressing ahead with its attempt to obtain patents for partial cDNA sequences. Astrue, who believes that such patents would impede biotechnological research of potential gene-based products, was able to stop the patent applications despite HHS director Louis Sullivan's support for NIH director Bernadine Healy's policy of seeking the patents.

Author: Anderson, Christopher
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1992
Science and technology policy, United States. Department of Health and Human Services, Astrue, Michael

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


NIH cDNA patent rejected; backers want to amend law

Article Abstract:

The National Institutes of Health (NIH) has failed to obtain patents on over 2,000 complementary DNA (cDNA) sequences. The Patent Office denied the NIH's application because many of the sequences had small fragments that were present in already published sequences. The Patent Office's interim decision may establish a precedent against patenting genes whose sequences have any resemblance to previously published sequences. However, the NIH is appealing the decision.

Author: Anderson, Christopher
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1992
Cases, Patent law, United States. Patent and Trademark Office

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Intellectual property, United States. National Institutes of Health, Antisense DNA
Similar abstracts:
  • Abstracts: From cell line to brain. Genetic evidence that relative synaptic efficacy biases the outcome of synaptic competition
  • Abstracts: Cash limits curb Max Planck Society's plans in the east. Max Planck expands toward the east. Max Planck supports research in east as cost of reunification climbs
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2026 Advameg, Inc.